Protective effect of parvalbumin on excitotoxic motor neuron death

Experimental Neurology

Volumn 174, Issue 2, 2002, Pages 150-161

  Van Den Bosch, L ^a   Schwaller, B ^b   Vleminckx, V ^a   Meijers, B ^a   Stork, S ^c   Ruehlicke, T ^b   Van Houtte, E ^a   Klaassen, H ^a   Celio, M R ^b   Missiaen, L ^a   Robberecht, W ^a   Berchtold, M W ^c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ALS; AMPA receptor; Amyotrophic lateral sclerosis; Calcium buffering; Calcium binding proteins; Excitotoxicity; Kainic acid; Motor neuron; Parvalbumin

Indexed keywords

AMPA RECEPTOR; EXCITOTOXIN; KAINIC ACID; PARVALBUMIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL PROTECTION; CONTROLLED STUDY; DEPOLARIZATION; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MOTONEURON; MOUSE; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL; TRANSGENIC MOUSE;

EID: 0036219315     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7858     Document Type: Article

References (47)

1. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis
2. Parvalbumin overexpression alters calcium homeostasis and prolongs survival in a transgenic model of familial amyotrophic lateral sclerosis
3. Cultured motoneurons possess calcium-permeable AMPA receptors
4. Structural organization and chromosomal assignment of the parvalbumin gene
5. 2+ overload and ROS generation in spinal motor neurons in vitro
6. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro
7. Production and analysis of transgenic mice with ectopic expression of parvalbumin
8. Isolation and characterization of mouse Thy-1 genomic clones
9. Calcium buffering properties of calbindin D28K and parvalbumin in rat sensory neurones
10. Deficiency in parvalbumin increases fatigue-resistance in fasttwitch muscle and upregulates mitochondria
11. From Charcot to SOD1: Mechanisms of selective motor neuron death in ALS
12. Parvalbumin is a marker of ALS-resistant motor neurons
13. Isolation of a rat parvalbumin gene and full length cDNA
14. 2+ increments in a single smooth muscle cell
15. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: Molecular mechanisms of neuronal death and protection
16. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform
17. Characterization of the AMPA-activated receptors present on motoneurons
18. Developmental changes in the subcellular localization of calretinin
19. Expression of the calcium-binding protein, parvalbumin, in cultured cortical neurons using a HSV-1 vector system enhances NMDA neurotoxicity
20. Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord
21. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD1 transgenic mouse model of amyotrophic lateral sclerosis
22. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease
23. Calbindin-D28k fails to protect hippocampal neurons against ischemia in spite of its cytoplasmic calcium buffering properties: Evidence from calbindin-D28k knockout mice
24. Calcium binding proteins in motoneurons at low and high risk for degeneration in ALS
25. 2+] transients of neuronal dendrites
26. Endogenous calcium buffering in motoneurones of the nucleus hypoglossus from mouse
27. Activity-related calcium dynamics in motoneurons of the nucleus hypoglossus from mouse
28. Gene transfer of calbindin D28k cDNA via herpes simplex virus amplicon vector decreases cytoplasmic calcium ion response and enhances neuronal survival following glutamatergic challenge but not following cyanide
29. Calcium-dependent inactivation of high-threshold calcium currents in human dentate gyrus granule cells
30. Calcium dynamics and buffering in motoneurones of the mouse spinal cord
31. Calbindin D28K gene transfer via herpes simplex virus amplicon vector decreases hippocampal damage in vivo following neurotoxic insults
32. Tetanus relaxation of fast skeletal muscles of the mouse made parvalbumin deficient by gene inactivation
33. Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: Evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS
34. The pathogenesis of amyotrophic lateral sclerosis
35. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis
36. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity
37. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms
38. Calretinin-immunoreactivity during postnatal development of the rat isocortex: A qualitative and quantitative study
39. A polyclonal goat antiserum against the calcium-binding protein calretinin is a versatile tool for various immunochemical techniques
40. Prolonged contraction-relaxation cycle of fast-twitch muscles in parvalbumin knockout mice
41. Different receptors mediate motor neuron death induced by short and long exposures to excitotoxicity
42. 2+-permeable AMPA receptors and selective vulnerability of motor neurons
43. AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability
44. AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability
45. Glial cells potentiate kainate-induced neuronal death in a motoneuron-enriched spinal coculture system
46. Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease
47. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: A molecular determinant of selective vulnerability in amyotrophic lateral sclerosis